Article Details

Semorinemab Demonstrates Safety, But No Slowing of Alzheimer Disease Progression

Retrieved on: 2022-06-22 15:15:19

Tags for this article:

Click the tags to see associated articles and topics

Semorinemab Demonstrates Safety, But No Slowing of Alzheimer Disease Progression. View article details on hiswai:

Excerpt

To the study authors' knowledge, this was the first published phase 2 data of an antitau monoclonal antibody in prodromal to mild AD.

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up